Evidence map›Paper›PMID 26907388›Full record

ArticlePlacenta2016

Relation of FTO gene variants to fetal growth trajectories: Findings from the Southampton Women's survey.

S J Barton, M Mosquera, J K Cleal, A S Fuller, S R Crozier, C Cooper, H M Inskip, J W Holloway, R M Lewis, K M Godfrey

Open access · hybridAbstract read
In one paragraph

Article in Placenta, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. RNA NCell communication and signaling : CCS · 2023
    Review
  5. Article
  6. Article
  7. Epitranscriptomic profiling in human placenta: N6-methyladenosine modification at the 5'-untranslated region is related to fetal growth and preeclampsia.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

S J BartonMRC Lifecourse Epidemiology Unit, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK. Electronic address: S.J.Barton@soton.ac.uk.
M MosqueraInstitute of Developmental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK; Department of Physiological Sciences, Faculty of Health, University of Valle, Cali, Colombia.
J K ClealInstitute of Developmental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK.
A S FullerMRC Lifecourse Epidemiology Unit, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK.
S R CrozierMRC Lifecourse Epidemiology Unit, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK.
C CooperMRC Lifecourse Epidemiology Unit, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK; NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, OX1 2JD, UK.
H M InskipMRC Lifecourse Epidemiology Unit, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK.
J W HollowayHuman Genetics and Genomic Medicine, Human Development & Health, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK.
R M LewisInstitute of Developmental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK.
K M GodfreyMRC Lifecourse Epidemiology Unit, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, SO16 6YD, UK.
University of Southampton · GBMRC Lifecourse Epidemiology Unit · GBUniversidad del Valle · CO

Funding

Arthritis Research UK 17702British Heart Foundation RG/07/009/23120Department of Health SOUDIBRU-2008-1Medical Research Council MC_U147574222Medical Research Council MC_U147574226Medical Research Council MC_U147585819Medical Research Council MC_U147585827Medical Research Council MC_UP_A620_1014Medical Research Council MC_UP_A620_1017Medical Research Council MC_UU_12011/1Medical Research Council MC_UU_12011/4Medical Research Council MR/J000094/1
6 · The paper itself

Abstract

introductionPlacental function is an important determinant of fetal growth, and fetal growth influences obesity risk in childhood and adult life. Here we investigated how FTO and MC4R gene variants linked with obesity relate to patterns of fetal growth and to placental FTO expression.

methodsSouthampton Women's Survey children (n = 1990) with measurements of fetal growth from 11 to 34 weeks gestation were genotyped for common gene variants in FTO (rs9939609, rs1421085) and MC4R (rs17782313). Linear mixed-effect models were used to analyse relations of gene variants with fetal growth.

resultsFetuses with the rs9939609 A:A FTO genotype had faster biparietal diameter and head circumference growth velocities between 11 and 34 weeks gestation (by 0.012 (95% CI 0.005 to 0.019) and 0.008 (0.002-0.015) standard deviations per week, respectively) compared to fetuses with the T:T FTO genotype; abdominal circumference growth velocity did not differ between genotypes. FTO genotype was not associated with placental FTO expression, but higher placental FTO expression was independently associated with larger fetal size and higher placental ASCT2, EAAT2 and y + LAT2 amino acid transporter expression. Findings were similar for FTO rs1421085, and the MC4R gene variant was associated with the fetal growth velocity of head circumference. DISCUSSION: FTO gene variants are known to associate with obesity but this is the first time that the risk alleles and placental FTO expression have been linked with fetal growth trajectories. The lack of an association between FTO genotype and placental FTO expression adds to emerging evidence of complex biology underlying the association between FTO genotype and obesity.

Indexed as

Alpha-Ketoglutarate-Dependent Dioxygenase FTOBirth WeightCephalometryCross-Sectional StudiesFemaleFetal DevelopmentFetusGenetic Predisposition to DiseaseGestational AgeHumansInfant, NewbornMaleObesityPolymorphism, Single NucleotidePregnancyRisk FactorsAlpha-Ketoglutarate-Dependent Dioxygenase FTOFTO protein, humanFetal growth trajectoriesFTO genotypeMC4R genotypePlacental amino acid transporter expressionPlacental FTO expression

Identifiers

PMID26907388
PMCPMC4776702
OpenAlexW2197724806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.